Mukka Proteins Declines 6.37%: Four Key Factors Behind the Steep Slide

3 hours ago
share
Share Via
Mukka Proteins Ltd’s stock endured a challenging week from 23 to 27 March 2026, declining by 6.37% to close at Rs.19.71, significantly underperforming the Sensex’s 1.46% fall over the same period. The stock hit fresh 52-week and all-time lows amid persistent financial headwinds, technical weakness, and subdued investor sentiment, despite a brief positive quarterly earnings report in December 2025.

Key Events This Week

23 Mar: Stock opens at Rs.20.45, down 2.85%

24 Mar: Hits 52-week and all-time low of Rs.20

25 Mar: Minor dip to Rs.20.51, slight volume drop

27 Mar: Closes at fresh 52-week low Rs.19.71, down 3.90%

Week Open
Rs.20.45
Week Close
Rs.19.71
-6.37%
Week Low
Rs.19.71
Sensex Change
-1.46%

23 March 2026: Weak Start Amid Broader Market Sell-Off

Mukka Proteins Ltd began the week at Rs.20.45, down 2.85% from the previous close of Rs.21.05. This decline coincided with a sharp Sensex drop of 3.13%, reflecting a broadly negative market environment. The stock’s volume was moderate at 39,039 shares, indicating cautious trading. The early weakness set the tone for the week, with the stock trading below all key moving averages, signalling bearish momentum.

24 March 2026: Stock Hits 52-Week and All-Time Low of Rs.20

On 24 March, Mukka Proteins’ share price fell further to Rs.20, marking both a 52-week and all-time low. This represented a day decline of 1.47%, underperforming the Sensex, which gained 1.95% that day. The stock’s fall to this milestone reflected ongoing challenges, including a prolonged downtrend and technical weakness. Delivery volumes increased by nearly 50% compared to the five-day average, indicating heightened selling pressure. Despite the broader market’s positive movement, the stock’s fundamentals and technicals remained under strain.

25 March 2026: Slight Recovery but Volume Drops

The stock marginally recovered to Rs.20.51, a 0.44% gain from the previous day, though still below the week’s opening price. Volume declined sharply to 19,499 shares, suggesting reduced trading interest. The Sensex continued its upward trajectory, rising 1.93%. This divergence highlighted the stock’s relative weakness amid a recovering market. Technical indicators remained bearish, with the stock trading below all major moving averages and resistance levels at Rs.22.04 (20-day) and Rs.23.74 (100-day) remaining intact.

Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!

  • - Highest rated stock selection
  • - Multi-parameter screening cleared
  • - Large Cap quality pick

View Our Top 1% Pick →

27 March 2026: Fresh 52-Week Low Amid Continued Market Pressure

The week closed on a weak note with Mukka Proteins Ltd’s stock falling to Rs.19.71, a 3.90% decline on the day and a fresh 52-week low. This drop occurred alongside a 2.11% fall in the Sensex, reflecting a broadly bearish market mood. The stock’s volume rose to 31,758 shares, signalling renewed selling interest. Despite outperforming its sector by 0.77% on the day, the stock’s overall weekly performance was poor, losing 6.37% compared to the Sensex’s 1.46% decline. Technical indicators continued to signal bearish momentum, with the stock trading below all key moving averages and facing resistance at Rs.21.79 (20-day moving average).

Weekly Price Performance: Mukka Proteins Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-03-23 Rs.20.45 -2.85% 32,377.87 -3.13%
2026-03-24 Rs.20.54 +0.44% 33,009.57 +1.95%
2026-03-25 Rs.20.51 -0.15% 33,645.89 +1.93%
2026-03-27 Rs.19.71 -3.90% 32,935.19 -2.11%

Key Takeaways: Strengths and Cautionary Signals

Financial Performance: Despite the ongoing downtrend, Mukka Proteins reported a positive quarterly performance in December 2025, with net sales surging 137.6% to Rs.653.50 crores and PAT doubling to Rs.23.75 crores. However, this improvement has yet to translate into sustained stock price recovery.

Valuation and Leverage: The stock trades at a P/E of approximately 14 times and a P/BV of 1.38 times, with an enterprise value to EBITDA ratio of 10.66 times, suggesting a valuation discount relative to peers. The company’s high Debt to EBITDA ratio of 5.26 times and net debt to equity ratio of 1.25 indicate elevated leverage and financial risk.

Technical Indicators: The stock remains below all key moving averages, with bearish MACD and Bollinger Bands signals on weekly charts. Monthly RSI shows some bullish tendencies, but overall momentum remains weak. Increased delivery volumes on down days reflect selling pressure.

Institutional Interest: Institutional holdings have declined by 1.5% in the previous quarter to just 1.86%, signalling reduced confidence from large investors.

Market and Sector Context: The broader FMCG and aquaculture sectors have faced headwinds, with sector declines of around 3.5%. The Sensex’s proximity to its 52-week low and bearish moving averages further constrain market sentiment.

Is Mukka Proteins Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Conclusion: Sustained Pressure Amid Mixed Signals

Mukka Proteins Ltd’s stock performance this week reflects continued downward pressure amid a challenging financial and market environment. The stock’s 6.37% weekly decline outpaced the Sensex’s 1.46% fall, underscoring its relative weakness. Despite a positive quarterly earnings report in December 2025, the company’s high leverage, modest profitability, and diminished institutional interest weigh heavily on investor sentiment.

Technical indicators predominantly signal bearish momentum, with the stock trading below all major moving averages and facing resistance at key levels. The broader FMCG and aquaculture sectors’ weakness, combined with a cautious market backdrop, further constrain prospects for a near-term recovery.

Investors should note the valuation discount relative to peers but remain mindful of the company’s structural challenges and ongoing downtrend. The stock’s recent lows mark significant milestones in its prolonged decline, with no clear reversal signals emerging this week.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News